ARRY - Array BioPharma Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 510.37B
Enterprise Value 310.02B
Trailing P/E N/A
Forward P/E 1-132.83
PEG Ratio (5 yr expected) 1-9.30
Price/Sales (ttm)53.47
Price/Book (mrq)34.16
Enterprise Value/Revenue 351.66
Enterprise Value/EBITDA 6-85.78

Trading Information

Stock Price History

Beta (3Y Monthly) 1.65
52-Week Change 3184.69%
S&P500 52-Week Change 36.70%
52 Week High 347.05
52 Week Low 312.56
50-Day Moving Average 341.33
200-Day Moving Average 326.83

Share Statistics

Avg Vol (3 month) 35.81M
Avg Vol (10 day) 34.06M
Shares Outstanding 5221.75M
Float 220.88M
% Held by Insiders 10.38%
% Held by Institutions 1100.68%
Shares Short (Jun 28, 2019) 427.83M
Short Ratio (Jun 28, 2019) 42.98
Short % of Float (Jun 28, 2019) 416.54%
Short % of Shares Outstanding (Jun 28, 2019) 412.47%
Shares Short (prior month May 31, 2019) 427.43M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Jun 30, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin -65.01%
Operating Margin (ttm)-61.32%

Management Effectiveness

Return on Assets (ttm)-13.98%
Return on Equity (ttm)-44.50%

Income Statement

Revenue (ttm)193.98M
Revenue Per Share (ttm)0.90
Quarterly Revenue Growth (yoy)33.40%
Gross Profit (ttm)33.44M
EBITDA -116.82M
Net Income Avi to Common (ttm)-126.11M
Diluted EPS (ttm)-0.59
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)423.09M
Total Cash Per Share (mrq)1.91
Total Debt (mrq)134.24M
Total Debt/Equity (mrq)44.51
Current Ratio (mrq)5.70
Book Value Per Share (mrq)1.36

Cash Flow Statement

Operating Cash Flow (ttm)-116.06M
Levered Free Cash Flow (ttm)-57.37M